From Our Web Site
Talecris has become one of the state's largest and fastest-growing biotechnology companies, employing 2,300 in the state and more than 4,500 globally.
UNC Chapel Hill was picked by the NIH to receive as much as $20 million to study the links between genetics and cancer.
Durham contract research organization Quintiles has launched a free Web site to give people comprehensive information about participating in clinical trials.
RTP-based Metabolon has applied its metabolomics know-how to pinpoint a suspected cause for gum disease.
Scientists from Duke and UNC were among panelists who published a review concluding there is no scientific link to adverse health issues for people drinking milk from cows given recombinant bovine somatotropin.
The grant will allow scientists to improve understanding of psychiatric disorders by fusing brain and behavior sciences.
One of the winners, Joseph DeSimone, is a chemistry professor at UNC and a professor in chemical engineering at N.C. State as well as an entrepreneur who co-founded he local firm Liquidia.
The Durham-based company will add sales reps to co-promote the drug, used for treating overactive bladder.
Research Triangle Park-based firm has opened a manufacturing site for investigational medical products within its existing manufacturing facility in Ferentino, Italy.
Durham's Oxygen Biotherapeutics has filed a patent application for a self-propelled compressor device that can deliver a quick jolt of its oxygen-carrying Oxycyte product as a first-aid treatment for victims of heart attacks and strokes.
Durham contract biopharmaceutical manufacturer KBI Biopharma has raised nearly $10 million in new funding, according to Triangle Business Journal.
|